Dallas, TX 7/7/2008 2:15:22 AM
News / Finance

OTCPicks.com Stocks to Watch for Monday, July 7th NUBV, AOGN, ATHX, ZYNX

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

 

Our Stocks to Watch tomorrow include NutriPure Beverages Inc. (OTC: NUBV), Avalon Oil & Gas Inc. (OTCBB: AOGN), Athersys Inc. (NASDAQ: ATHX), Zynex Medical Holdings Inc. (OTCBB: ZYNX)

 

For the complete newsletter please visit: http://www.otcpicks.com/stocks-to-watch/index.php

 

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/

 

NUTRIPURE BEVERAGES INCORPORATED (OTC: NUBV)

"Up 100.00% on Thursday"

 

Detailed Quote: http://www.otcpicks.com/quotes/NUBV.php

 

NutriPure Beverages, Inc. is bringing to market a complete line of nutrient-enhanced bottled water products under the NU2O label. These products are created using a patented technology that is more efficient and less costly than any other currently in use. This unique process adds organic nutrients to water without adding masking flavors, colors or sweeteners, yielding premium enhanced water products that contain no calories, no carbohydrates, no colors and most importantly, no flavors other than pure water. The process is further enhanced using desirable “cold-fill” techniques, which save energy and reduce harmful, “plastic chemical leaching” into the product. The company intends to market a full line of Nu2O nutrient-enhanced water products which will compete with currently available products. Nu2O products will include those that provide vitamin support for general health, a diet formulation for weight watchers, an immune booster, an energy and fitness drink, and additional products to be announced later. For more information, visit http://www.nutripurebeverages.com/.

 

AVALON OIL & GAS INCORPORATED (OTCBB: AOGN)

"Up 53.15% on Thursday"

 

Detailed Quote: http://www.otcpicks.com/quotes/AOGN.php

 

Avalon Oil & Gas, Inc. engages in the acquisition of producing oil and gas properties in the United States. It holds 50% working interest in the J.C. Kelly wellbore, a 121.9 acre lease in Wood County, Texas; the E.A. Chance wellbores, a 40 acre lease in Camp County, Texas; 50% working interest in the Dixon Heirs, Deltic Farms and Timber, the Gunn wells, and associated units and leases, in Miller County, Arkansas; 10% working interest in 13 wellbores located in Upshur County, Texas; 25% working interest in a six well production property located in Grant Parish, Louisiana; and 15% working interest in the Janssen prospect in Karnes County, Texas. The company also holds 20% interest in the Talora Block and 15% interest in the Mecaya Block. Avalon Oil & Gas, through its subsidiaries, owns licenses for the mitigation of paraffin wax deposition from crude oil using ultrasonic waves; borehole casing technology; and to a system for determining the presence and location of leaks in underground pipes. Avalon Oil & Gas, Inc. has a strategic alliance with UTEK Corporation to develop a portfolio of new technologies for the oil and gas industry. The company is based in Minneapolis, Minnesota.

 

ATHERSYS INCORPORATED (NASDAQ: ATHX)

"Up 21.74% on Thursday"

 

Detailed Quote: http://www.otcpicks.com/quotes/ATHX.php

 

Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic product candidates in multiple disease areas in the United States. Its product pipeline includes ATHX-105, a Phase I clinical trial product for the treatment of obesity. The company also develops orally active pharmaceutical products for the treatment of central nervous system disorders that include sleep disorders, such as narcolepsy or excessive daytime sleepiness; and other potential indications comprising attention deficit hyperactivity disorder and other cognitive disorders. In addition, Athersys, through its product co-development collaboration with Angiotech Pharmaceuticals, Inc., develops MultiStem for the treatment of damage caused by myocardial infarction and peripheral vascular disease, as well as for hematopoietic stem cell transplant support, ischemic stroke, and other disease indications. The company was founded in 1995 and is based in Cleveland, Ohio.

 

ZYNEX MEDICAL HOLDINGS INCORPORATED (OTCBB: ZYNX)

"Up 17.14% on Thursday"

 

Detailed Quote: http://www.otcpicks.com/quotes/ZYNX.php

 

Zynex Medical Holdings, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. It primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's products are useful for patients suffering with impaired mobility from stroke and spinal cord injury, as well as for those suffering from debilitating and chronic pain. Its electrotherapy products include IF 8000, an interferential and muscle stimulation device; IF 8100, a fixed program version of the IF8000; TruWave, a dual channel transcutaneous electrical nerve stimulation (TENS) device; E-Wave, a dual channel neuromuscular electrical stimulation device (NMES); and NM 900, an EMG triggered electrical stimulation device. In addition, the company distributes Elpha 3000, a dual channel NMES device; Conti4000, an electrical stimulation device for incontinence treatment; ValuTENS and Elpha 1000 Dual Channel TENS Devices; DCHT, a cervical traction device; LHT, a lumbar traction device; and electrodes that are re-usable for delivery of electrical current to the body. Zynex Medical Holdings markets its products through commissioned, independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company was founded in 1998 and is headquartered in Littleton, Colorado.

 

About OTCPicks.com

 

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

 

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

 

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

 

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.